Oestrogen plus progestin doubles the risk of dementia in post-menopausal women: Commentary

Evidence-Based Mental Health

Volumn 6, Issue 4, 2003, Pages 111-

  Sherwin, Barbara B ^a   McGill, James ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750695508     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/ebmh.6.4.111     Document Type: Note

References (8)

1. McEwen BS. Estrogen action throughout the brain. Recent Prog Horm Res 2002;57:357-384.
2. Sherwin BB. Estrogen and cognitive functioning in women. Endocrine Rev. 2003;24:133-151. (Pubitemid 36515282)
3. Rapp SR, Espeland MA, Shumaker SA et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women. The Women's Health Initiative Memory study: a randomized controlled trial. JAMA 2003; 289: 2663-2672.
4. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behaviour in postmenopausal women. J Clin Endocrinol Metab. 1991;72:336-343. (Pubitemid 21921696)
5. Rice MM, Graves AB, McCurry SM et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women; the Kane project. Arch Intern Med 2000;160:1641-1649. (Pubitemid 30367903)
6. Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging 200;21:107-116.
7. Matthews KA, Cauley J, Yaffe K, Zmuda J. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999;47:518-523. (Pubitemid 29215577)
8. Zandi PP, Carlson MC, Plassman BL et al. Hormone replacement therapy and incidence of Alzheimer's disease in older women: the Cache County Study. J Am Med Assoc 2002;288:2123-2129. (Pubitemid 35265379)